Literature DB >> 30056525

Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.

Michele Maria Luchetti1, Devis Benfaremo2, Anna Campanati3,4, Elisa Molinelli3,4, Monia Ciferri2, Serena Cataldi2, William Capeci2, Marco Di Carlo5, Anna Maria Offidani3,4, Fausto Salaffi5, Armando Gabrielli2.   

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory autoimmune arthritis, occurring in patients with psoriasis (Pso), that may affect the whole musculoskeletal system but also nails, eye, and gastrointestinal tract. Dermatologists and rheumatologists usually manage Pso and PsA separately, but early diagnosis and integrated management could achieve better outcomes of both skin and musculoskeletal manifestations, thus improving the health-related quality of life (HRQoL) of patients. In this work, we have described a model of integrated dermo-rheumatologic approach for the early diagnosis of PsA and to present the outcomes of the multidisciplinary management of PsA patients after 48 weeks of follow-up. Pso patients complaining musculoskeletal symptoms were enrolled in a DErmo-Rheumatologic Clinic (DERC) in order to screen, classify, and treat patients with PsA, employing an operative working procedure and a specific flowchart. The integrated dermatologic and rheumatologic management of PsA patients allowed a prompt establishment of the diagnosis and the best therapeutic approach in these patients, with a significant improvement of skin and articular diseases and, eventually, a consistent amelioration of HRQoL. Dermatologists and rheumatologists usually manage the "psoriatic disease" in separated outpatient clinics. In our study, we have demonstrated that a combined DERC, by means of a tight cooperation between the dermatologist and the rheumatologist, which use a specific working procedure and treatment flowchart, may achieve the optimal clinical management of these patients, with a consistent clinical remission of the disease and a significant amelioration of the HRQoL.

Entities:  

Keywords:  Dermo-rheumatologic clinic (DERC); Health related quality of life; psoriatic disease

Mesh:

Year:  2018        PMID: 30056525     DOI: 10.1007/s10067-018-4238-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

1.  The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.

Authors:  Laura C Coates; William Tillett; David Chandler; Philip S Helliwell; Eleanor Korendowych; Stuart Kyle; Iain B McInnes; Susan Oliver; Anthony Ormerod; Catherine Smith; Deborah Symmons; Nicola Waldron; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2013-07-25       Impact factor: 7.580

Review 2.  Psoriatic Arthritis.

Authors:  Christopher T Ritchlin; Robert A Colbert; Dafna D Gladman
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

Review 3.  Biologics in Inflammatory and Immunomediated Arthritis.

Authors:  Michele M Luchetti; Devis Benfaremo; Armando Gabrielli
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

4.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).

Authors:  L C Coates; T Aslam; F Al Balushi; A D Burden; Esther Burden-Teh; E Burden-The; A R Caperon; R Cerio; C Chattopadhyay; H Chinoy; M J D Goodfield; L Kay; S Kelly; B W Kirkham; C R Lovell; H Marzo-Ortega; N McHugh; R Murphy; N J Reynolds; C H Smith; E J C Stewart; R B Warren; R Waxman; H E Wilson; P S Helliwell
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

7.  Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.

Authors:  Jessica A Walsh; Kristina Callis Duffin; Gerald G Krueger; Daniel O Clegg
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

8.  Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.

Authors:  Michele Maria Luchetti; Devis Benfaremo; Francesco Ciccia; Laura Bolognini; Monia Ciferri; Alessia Farinelli; Matteo Rossini; Piergiorgio Mosca; Giovanni Triolo; Armando Gabrielli
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

9.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

10.  Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Authors:  Arthur Kavanaugh; Philip J Mease; Juan J Gomez-Reino; Adewale O Adebajo; Jürgen Wollenhaupt; Dafna D Gladman; Eric Lespessailles; Stephen Hall; Marla Hochfeld; ChiaChi Hu; Douglas Hough; Randall M Stevens; Georg Schett
Journal:  Ann Rheum Dis       Date:  2014-03-04       Impact factor: 19.103

View more
  14 in total

Review 1.  Multidisciplinary Management of Psoriatic Arthritis: The Benefits of a Comprehensive Approach.

Authors:  Elisa Visalli; Natascia Crispino; Rosario Foti
Journal:  Adv Ther       Date:  2019-02-25       Impact factor: 3.845

2.  Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.

Authors:  Kalliopi Klavdianou; Maria Stavropoulou; Pantelis Panagakis; Marina Papoutsaki; Alexandros Panagiotopoulos; Christos Koutsianas; Alexandros Stratigos; Dimitrios Rigopoulos; Dimitrios Vassilopoulos
Journal:  Rheumatol Int       Date:  2022-04-18       Impact factor: 2.631

3.  Clinicians' perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study.

Authors:  Daniel Sumpton; Elyssa Hannan; Ayano Kelly; David Tunnicliffe; Andrew Ming; Geraldine Hassett; Jonathan C Craig; Allison Tong
Journal:  Clin Rheumatol       Date:  2020-09-15       Impact factor: 2.980

4.  Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study.

Authors:  Ennio Lubrano; Andrea Delle Sedie; Marco Romanelli; Maria Sole Chimenti; Luca Bianchi; Stefano Piaserico; Catia De Felice; Dario Graceffa; Maria Ilenia De Andres; Salvatore Curatolo; Rosa Daniela Grembiale; Stefano Dastoli; Chiara Arcuri; Rosa Giuseppa Angileri; Francesca Prignano; Francesca Bandinelli; Elena Baldissera; Santo Raffaele Mercuri; Chiara Franchi; Matteo Longhi; Angela Patrì; Francesco Caso; Giuseppe Passiu; Maria Antonia Montesu; Simone Parisi; Elena Stroppiana; Genoveffa Scotto di Luzio; Giovanni Italiano; Sergio Di Nuzzo; Daniele Santilli; Laura Bigi; Federica Lumetti; Concetto Paolo Agnusdei; Maria Grazia Ferrucci; Giuliana Gualberti; Francesca Marando; Roberta Ramonda; Francesco Cusano
Journal:  Clin Rheumatol       Date:  2020-11-06       Impact factor: 2.980

5.  Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study.

Authors:  Phillip J Mease; Clive Liu; Evan Siegel; Heather Richmond; Meijing Wu; Liang Chen; Kevin Douglas; Benjamin Lockshin
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

6.  LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan.

Authors:  Masato Okada; Sarina Kurimoto; Fabiana Ganz; Wolf-Henning Boehncke
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

Review 7.  Multidisciplinary working in the management of axial and peripheral spondyloarthritis.

Authors:  Tania Gudu; Deepak R Jadon
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-10       Impact factor: 5.346

8.  Effectiveness of interdisciplinary combined dermatology-gastroenterology-rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial.

Authors:  Kasper Fjellhaugen Hjuler; Anders Dige; Jørgen Agnholt; Trine Bay Laurberg; Anne Gitte Loft; Louise Faurskov Møller; Robin Christensen; Lars Iversen
Journal:  BMJ Open       Date:  2021-04-28       Impact factor: 2.692

Review 9.  Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases.

Authors:  Anna Campanati; Emanuela Martina; Federico Diotallevi; Giulia Radi; Andrea Marani; Davide Sartini; Monica Emanuelli; George Kontochristopoulos; Dimitris Rigopoulos; Stamatis Gregoriou; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Improving the standard of care for patients with spondyloarthritis-related immune inflammatory conditions: results of a Delphi study and proposal for early detection.

Authors:  Pablo Coto; Sabino Riestra; Paloma Rozas; Ana Señaris; Rubén Queiro
Journal:  Ther Adv Chronic Dis       Date:  2020-02-12       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.